Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-10-16

Clinical Trial Update: Beneficial Effects of Grape Seed Proanthocyanidin Extrat on Progression of Atherosclerotic Plaques in Clinical Use [Phase 2]

View source ↗

Summary

Phase 2 trial update suggests grape seed proanthocyanidin extract slows progression of atherosclerotic plaques in the peripheral arteries.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Grape Seed Proanthocyanidin Extract (grape seed proanthocyanidin extract)

Snippet

Sponsor: Jie Qiu | Conditions: Atherosclerosis of Arteries of the Extremities, Unspecified | Phase 2 | Status: COMPLETED